‹ All Posts
Saurabh Tyagi--Clovek,Advisory

28th Aug · SEBI-Registered Analyst

DRREDDY
launches novel drug for chronic constipation management

DRREDDY
Laboratories has introduced Colozo, a generic drug for chronic constipation in India. This medication, Linaclotide, is approved by the USFDA. It addresses chronic idiopathic constipation and irritable bowel syndrome. This launch strengthens Dr Reddy's gastrointestinal segment. It follows the introduction of BixiBat in India last year. The company aims to improve patient care and serve 1.

#FundamentalViews#MacroViews#WatchOutFor#StockInNews#EquityResearch